Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Doximity (DOCS) Other Non-Current Liabilities (2021 - 2025)

Doximity has reported Other Non-Current Liabilities over the past 5 years, most recently at $9.4 million for Q1 2025.

  • Quarterly Other Non-Current Liabilities fell 13.88% to $9.4 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $9.4 million through Mar 2025, down 13.88% year-over-year, with the annual reading at $9.4 million for FY2025, 13.88% down from the prior year.
  • Other Non-Current Liabilities was $9.4 million for Q1 2025 at Doximity, up from $8.9 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $10.9 million in Q1 2024 and troughed at $904000.0 in Q3 2021.
  • The 5-year median for Other Non-Current Liabilities is $1.2 million (2023), against an average of $4.3 million.
  • Year-over-year, Other Non-Current Liabilities surged 921.31% in 2023 and then crashed 47.66% in 2024.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $905000.0 in 2021, then rose by 19.67% to $1.1 million in 2022, then skyrocketed by 503.14% to $6.5 million in 2023, then skyrocketed by 36.15% to $8.9 million in 2024, then grew by 5.51% to $9.4 million in 2025.
  • Per Business Quant, the three most recent readings for DOCS's Other Non-Current Liabilities are $9.4 million (Q1 2025), $8.9 million (Q4 2024), and $5.5 million (Q3 2024).